Introduction {#Sec1}
============

In early December 2019, a novel strain of coronavirus now known as coronavirus SARS (severe acute respiratory syndrome)-CoV-2, or COVID-19, broke out in Wuhan, China. The virus began to disseminate throughout the world, and on March 11, 2020, the World Health Organization (WHO) Director declared the 2019-nCoV outbreak a global pandemic, which classifies the outbreak as an international emergency \[[@CR1], [@CR2]\].

COVID-19 has severely altered the day-to-day life and operations for people, economies, and healthcare systems alike. The rapid spread of COVID-19 has created an expeditious implementation of new practices and principles that healthcare leaders have adopted in order to most effectively remain ahead of the curve. Unlike ever before, COVID-19 has highlighted geographical differences from provider to provider as to which methodologies were developed, how they were employed, and with what efficacy. In large part, these methodologies have been predicated upon characteristics specific to the host environment, such as viral seroprevalence, population density, socioeconomic factors, local governance, and resource limitations. For example, Milan, Italy, representative of a high population density and an overwhelming case load of COVID-19 positive patients, faces challenges distinct from those of Makwasa, Malawi, with lower population density and relatively low incidence of COVID-19.

Because the peak of COVID-19 cases have and will surge at different time points in different geographies, much can be learned about how various global providers have responded to the crisis \[[@CR2]--[@CR5]\]. Currently, there is a growing emphasis on the relevance of observational research in identifying factors, challenges, and responses to this pandemic among orthopaedic practices throughout the world \[[@CR6]--[@CR10]\]. Our team believes that there is value in learning from the experiences of orthopaedic professionals in many global settings, such that localized planning may transition from rapid-fire response to informed expectations and processes. Not only will these lessons allow us to better understand and overcome the current COVID-19 pandemic, but they will help the global orthopaedic community prepare for future outbreaks that may reach a scale such as the one we are living through today.

The goal of this project is to summarize the preparation, actions, lessons, and personal experiences of orthopaedic trauma surgeons and departments across the world in combating COVID-19. In doing so, we will shed light on current practices and challenges, which may help us manage the current pandemic in addition to preparing for future global pandemics that may arise.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

Survey participation was carried out in the month of April 2020 between April 16, 2020, and April 20, 2020. Participation in this cross-sectional questionnaire was voluntary, and orthopaedic trauma surgeons were included in the study based on voluntary interest.

Data acquisition {#Sec4}
----------------

In order to describe the trend of total cases and total deaths due to COVID-19, the Johns Hopkins University Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) and the Institute for Health Metrics and Evaluation (IHME) databases were referenced \[[@CR11], [@CR12]\]. Several time points were included throughout this five month span in order to understand the evolution of the case load and death rate.

Questionnaire {#Sec5}
-------------

A 20-item questionnaire was sent out to 150 orthopaedic trauma surgeons representing 42 countries across the globe who were identified based on professional relationships and/or prior involvement in international meetings either led or participated by the senior author. Each participant was first asked to identify personal demographics including city, country, and hospital of their orthopaedic practice. Participants were then asked a series of specific questions related to their orthopaedic practice in order to understand the setting (urban vs. rural), volume of orthopaedic cases pre- and during COVID-19, and types of procedures currently being performed during COVID-19.

Participants were then asked to delineate how COVID-19 has affected their orthopaedic practice in terms of number of orthopedic consultations per day, number of orthopaedic cases treated pre- and during COVID-19, as well as how the current orthopedic injuries presenting during COVID-19 compared with injury presentations prior to the outbreak.

Next, participants were asked to describe their adoption of telemedicine practices. Each participant differentiated between the adoption of telephone-only visits, telephone and video visits, or no adoption of telemedicine visits at all. Furthermore, participants were asked to describe how they believed the rapid changes in medicine that are occurring due to the COVID-19 pandemic would permanently affect their future practices after the global pandemic ends.

Each participant was then asked several questions with regard to the current state of equipment and personal protective equipment (PPE) at their hospital. If their facility was experiencing shortages, participants were asked to identify what was being done to address it. Additionally, participants were asked to identify whether all providers were given the same access to PPE or if certain departments (i.e., anesthesia or emergency medicine) had more access to PPE. Participants were then asked questions to categorize the level of COVID-19 testing currently taking place at their hospital and to describe policy changes at the hospital including restructuring to the staffing model and/or if orthopaedic residents/fellows/attendings at their hospital were tasked with working on non-orthopaedic hospital floors.

Lastly, participants were asked open-ended, free-text questions to identify the most significant challenges to their orthopaedic practice in dealing with COVID-19. This included what they wish they had known prior to the outbreak that would have helped them now; how they are addressing the challenges being presented by COVID-19; and any personal experience, thoughts, or opinions as a medical professional working in the COVID-19 pandemic in their respective country.

Analysis {#Sec6}
--------

Statistical analysis was made using JMP Pro 15 by SAS. The data coding was done by a single person and provided by the investigators. Descriptive statistics were reported for continuous variables and percentages for categorical variables.

Results {#Sec7}
=======

The questionnaire was completed by 63 orthopaedic trauma surgeons representing 28 different countries and 14 US states (Fig. [1](#Fig1){ref-type="fig"}). Of the surgeons who completed the survey, 19% practice in a rural area with an average of five orthopaedic surgeons in their hospital system, while 81% of respondents practice in an urban setting with an average of 29 orthopaedic surgeons in their hospital system. Furthermore, three out of the 28 represented countries are classified as low-income countries, and eight are classified as lower-middle-income countries (39% low- or middle-income countries) by the 2019 WHO designation \[[@CR13]\] (Table [1](#Tab1){ref-type="table"}). Given the global and regional diversity represented by our sample pool, each participant provides a unique perspective in terms of when and to what extent COVID-19 affected their orthopaedic practice. As seen in Fig. [2](#Fig2){ref-type="fig"}--c, several participants began to experience COVID-19 in mid-February with cases continuing to climb through mid-April, while some participants have yet to experience a significant case load of COVID-19 patients.Fig. 1Countries Represented by Survey Participants. Blue indicates a participating country. Dark Grey indicates a country where a questionnaire was sent, but no response was receivedTable 1Participants orthopedic trauma practice location, hospital size, and number of surgeonsCountryHospitalHospital size (\# of beds)Urban/rural\# of Orthopedic surgeonsArgentinaHospital Italiano de Buenos Aires750Urban60ArgentinaRamos Mejia Hospital150Urban16CanadaQE II Health Sciences Centre1100Urban15CanadaSunnybrook Health Sciences Centre1325Urban23CanadaFoothills Medical Center1200Urban19ColombiaFoundation Santa Fe de Bogota205Urban30ChileLas Condes Clinic253Urban42ChileHospital Militar de Santiago357Urban28ChinaNanfang Hospital2500Urban50ColombiaInstituto Colombiano del Dolor371Urban25ColombiaIPS Universitaria Sede Clínica León XII618Urban25EgyptAssiut University Hospital358Urban85EthiopiaBlack Lion (Tikur Anbessa) Hospital800Urban11EthiopiaSoddo Christian Hospital133Rural2GabonBongolo Hospital158Rural3GermanyUniversity of Freiburg Hospital1600Urban51GreeceIatriko Kentro383Urban10GuatemalaEl Pilar Hospital140Urban20HaitiHUP La Paix University Hospital300Rural6Hong KongQueen Mary Hospital1706Urban55Hong KongTseung Kwan O Hospital667Urban22IndiaGanga Hospital Coimbatore486Urban107ItalyHumanitas Research Institute162Urban60ItalyAzienda Ospedaliera Universitaria Policlinico600Urban14ItalyVito Fazzi Lecce800Urban13KenyaTenwek Hospital361Rural2MalawiMalamulo Adventist Hospital275Rural4New ZealandWaikato District Health Board600Urban18PakistanAga Khan University Hospital560Urban11PeruAmazonico Hospital120Rural3SingaporeTan Tock Seng Hospital1600Urban25South KoreaKyungpook National University Hospital951Urban35South KoreaKorea University Guro Hospital1050Urban16SpainVithas Hospital100Urban17SwedenSahlgrenska University Hospital2000Urban80SwedenLinköping University Hospital600Urban27SwitzerlandUnispital Zurich980Urban16SwitzerlandLuzerner Kantonsspital900Urban14SwitzerlandUniversity Hospital Basel670Urban25SwitzerlandKantonsspital Graubünden Hospital770Urban15TaiwanTaipei Veterans General Hospital, Taiwan3100Urban25ThailandChiang Mai University Hospital1400Urban20ThailandBangkok International Hospital580Urban25UKLeeds General Infirmary University Hospital1103Urban40UKUniversity College London hospital665Urban14USAUniversity of Missouri - Columbia SOM247Urban35USACentral Vermont hospital122Rural4USAJohns Hopkins Hospital1154Urban15USASanford Bemidji196Rural4USAProvidence St Peter's Hospital390Urban15USAOregon Health & Science University556Urban16USAErie County Medical Center906Urban20USALAC + USC Medical Center600Urban13USASt. Mary's Medical Center Hospital281Rural7USAMemorial Hospital of Sweetwater County58Rural3USAUniversity of New Mexico618Urban25USAOhio State University1113Urban33USAMayo Clinic Health System Eau Claire193Rural9USAStormont Vail Hospital586Rural10Fig. 2**a--c** COVID-19 cases by country between February 15, 2020, and April 15, 2020 \[[@CR11], [@CR12]\]. Low-income country represented with \*\*\*. Lower middle-income country represented with \*\*. Middle-income country represented with \*

While countrywide data is widely accessible in terms of total COVID-19 cases, it is difficult to glean specific regional and hospital ramifications of COVID-19 on a global scale. Consequently, each participant in the study was asked to identify the percentage of total patients in their intensive care unit (ICU) filled by COVID-19 (+) patients. Most respondents noted that their ICU was less than 50% filled by COVID-19 positive patients, while only a few respondents noted 100% capacity of their ICU by COVID-19 (+) patients (Table [2](#Tab2){ref-type="table"}). In addition to differences in the number of COVID-19 patients in the ICU of hospitals across the world, the level of laboratory testing at each hospital varied dramatically where 83% reported testing of symptomatic patients only, 56% reported testing of surgical patients, 40% reported testing healthcare workers, and 10% reported no testing at all (Table [3](#Tab3){ref-type="table"}).Table 2Percentage of ICU occupied by COVID-19 (+) patientsPercentage\# of Hospitals\# of Total100%34.84%76--99%58.06%51--75%711.29%\< 50%4775.81%The majority of respondents noted less than 50% capacity of their ICU beds by COVID-19 (+) patients. One respondent left this question unansweredTable 3COVID-19 (+) laboratory testing by HospitalPercentage\# of Hospitals\# of TotalNo testing69.52%Symptomatic patients5282.54%Surgical patients3555.56%Healthcare workers2539.68%The majority of respondents noted testing of symptomatic patients for COVID-19. The specific type of COVID-19 test was not asked

The effects of COVID-19 are not only causing significant changes in the ICUs of each of the participating hospitals but greatly impacting orthopaedic trauma departments in terms of the number and type of orthopaedic procedures being performed. Of the respondents, 68% reported their hospital typically performs more than 40 orthopaedic procedures per week prior to COVID-19. However, now, just 5% of participating hospitals are performing more than 40 procedures per week, with 80% performing less than 20 procedures per week (Fig. [3](#Fig3){ref-type="fig"}). Additionally, the type of procedures being performed has been affected with just 17% of participating hospitals currently performing elective orthopaedic surgery (Table [4](#Tab4){ref-type="table"}).Fig. 3Orthopaedic procedures performed prior to COVID-19 pandemic and during COVID-19 pandemic. Many orthopaedic departments who typically performed 40 + surgeries per week are now performing less than 20 per weekTable 4Types of surgeries performed during COVID-19 pandemicType of surgery\# of Hospitals\# of TotalEmergency/trauma (e.g., compartment syndrome, open fracture)63100.00%Urgent trauma (e.g., femur fracture, hip fracture)6298.41%Sub-acute trauma (e.g., ankle fracture, humerus fracture)5790.48%Elective1117.46%Every respondent noted their hospital performing emergency/trauma surgeries, with only a small percentage still performing elective orthopedic surgery

In addition to the number and types of orthopaedic surgery being significantly altered during COVID-19, the actual type and mechanism of injury of patients itself are also different, as reported by 91% of participants (Table [5](#Tab5){ref-type="table"}). When asked, "Have you observed differences in mechanism of injury trends in your practice since the onset of COVID-19?", 65% of participants answered yes, while 56% identified specific patterns of change in their patient pool. Their responses shed light on how the current crisis affects orthopaedic epidemiological trends across different geographical settings.Table 5Volume of orthopaedic injuries and changes in mechanism of injury during COVID-19Volume of cases\# of Hospitals\# of TotalIncreased46.35%Decreased5790.48%No change23.17%Mechanism of injury\# of Hospitals\# of TotalChange4165.08%No change2234.92%The majority of respondents noted a decrease in total orthopedic volume, many of which noting a specific change in mechanism of injury as well

Orthopaedic departments themselves are also undergoing massive change during the COVID-19 pandemic. Of the respondents, 30% noted that their orthopaedic department has had to deploy orthopaedic residents, fellows, or attendings to work on non-orthopedic floors in order to help mitigate the overwhelming patient load. Furthermore, changes have been made to the department staffing models including rotating surgical teams with implemented isolation to minimize cross-exposure (56%), reduction of personnel in operating rooms and on site to the minimum necessary to provide coverage, and lastly, the introduction of virtual meetings and case presentations via various video platforms (Table [6](#Tab6){ref-type="table"}).Table 6Staffing changes during COVID-19Orthopaedic surgeons working on non-orthopedic floors\# of Hospitals\# of TotalYes1930.16%No4469.84%Changes to staffing model\# of Hospitals\# of TotalRotating surgical teams with implemented isolation to minimize cross-exposure3555.56%No changes to organizational structure1828.57%Other1015.87%Many departments have implemented rotating surgical teams to minimize cross-exposure, and some orthopedic departments have had deployed surgeons to work on non-orthopedic floors

While orthopaedic departments are undergoing rapid change due to the COVID-19 pandemic, the departments and hospitals alike are experiencing significant shortages in equipment and/or personal protective equipment (PPE). Of the respondents, 85% noted some shortage of PPE, with the most common being N-95 masks (57%), followed by surgical masks (44%), face shields (41%), and hand sanitizer (29%). Many respondents' departments and hospitals were responding to these shortages through the reduction of allotted PPE per day (57%), increased purchasing, and distribution from medical supply companies (51%), as well as donations by community members/businesses (40%). Additionally, the procurement of PPE within each hospital differed slightly in that at 58% of participating hospitals, intensivists/anesthesiologists received PPE first, with 52% of respondents noting equal distribution of PPE throughout all providers (Figs. [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, and [6](#Fig6){ref-type="fig"}).Fig. 4Equipment and PPE shortages recorded by respondents. Most respondents (86%) indicated a shortage in PPE or equipment, while only 14% indicated no shortagesFig. 5Hospital mechanisms to address shortages in PPE. Many hospitals are relying on a reduction in PPE allotment, increased supply, and donations by community/local businesses in order to maintain adequate PPE levelsFig. 6Method of allotment of PPE by specific hospitals. Many hospitals are allotting PPE to intensivists/anesthesiologists first, while some are providing equal PPE to all providers

Another remarkable change in orthopaedic departments across the world has been the adoption of telemedicine into their practice. Of the participating orthopaedic departments, 73% reported the adoption of telemedicine, with the majority implementing telephone and video visits (48%) and some only telephone visits (25%) (Fig. [7](#Fig7){ref-type="fig"}). Of the respondents representing high-income countries, 78% noted the adoption of telemedicine, while 55% of LMICs adopted telemedicine practices. Furthermore, 54% of total respondents noted that telemedicine would most likely become a permanent change to their practice post COVID-19, with an even greater percentage (74%) of those who have already implemented telemedicine practices in response to COVID-19 recognizing it would likely be a permanent change. Of those that identified telemedicine as a more permanent change to their practice, 80% represented HICs, and 20% represented LMICs.Fig. 7Number of countries implementing telemedicine. Most countries are implementing telemedicine visits in the wake of the COVID-19 pandemic. Six out of 11 low- or middle-income countries (55%) have implemented telemedicine, while 14 out of 18 high-income countries (78%) have implemented telemedicine

Discussion {#Sec8}
==========

This paper includes the largest sample size of orthopaedic trauma surgeons describing the effects of COVID-19 on their practice to date, which allows us to highlight the environment of orthopaedic trauma practices across the world currently combatting COVID-19. This survey includes the responses from 63 surgeons who represent 59 hospitals worldwide who themselves represent a total of 47,309 hospital beds and 1557 orthopaedic surgeons in their facilities (Table [1](#Tab1){ref-type="table"}). While there are still many challenges to overcome, several lessons can be learned from the experiences presented by our study participants.

One of the main issues highlighted by emerging literature on COVID-19 is the shortage of equipment, specifically ventilators, as well as PPE, and what structural changes and policies have been implemented in order to help mitigate this. Many of our respondents echoed this concern, responding to the question, "What do you wish you would have known prior to this outbreak that would have helped alleviate challenges you are experiencing now?", with remarks related to PPE. Respondents noted their wish to know what the limit of PPE was at their facility prior to the pandemic, for the ability to stockpile PPE for their staff prior to the outbreak, and for better storage capacities of PPE in general as well as earlier policies to address the shortages. The results of this survey highlight that the shortages are not unique to one region or country but rather a global issue. Several strategies have worked well for our respondents, including donation of PPE by local community members and businesses as well as reduction in allotted PPE per provider per day. Additionally, prioritizing the types of providers at highest risk of exposure to the virus has allowed hospitals to maintain supplies at a level necessary to continue to function and to treat patients during this pandemic. However, future planning must account for the shortages we are facing now through coordinated local and country responses, as well as hospital specific responses to implement the policies noted above earlier, and to a greater extent.

Another rapidly emerging topic in the precipitous spread of COVID-19 across the world has been the swift adoption of telemedicine. There have been many hypotheses about how the current healthcare conditions may affect the operations of clinical care moving forward, one of the main variables in this discussion being the use of telemedicine \[[@CR14]--[@CR17]\]. In the USA, the Centers for Medicare & Medicaid Services (CMS) broadened telehealth indications to allow doctors to provide more services, and private health insurers were soon to follow \[[@CR18]\]. As a result, millions of patients and providers in the USA are using telemedicine for the first time. Berkson et al. recently published the first protocol and methods to conduct a virtual orthopaedic examination via telemedicine \[[@CR14]\]. However, what is unclear is how these updated guidelines affect orthopaedic practices going forward and whether telemedicine has been embraced in the global orthopedic context.

This sample supports two conclusions in regard to telemedicine adoption: (1) the majority of orthopaedic trauma surgeons worldwide have implemented telehealth capabilities and (2) the majority of orthopaedic trauma surgeons worldwide believe that the use of telemedicine will be a permanent change in their practice moving forward.

Limitations {#Sec9}
===========

Our study has several limitations. First, our sampling technique was specific to academic surgeons who had attended professional meetings or formed professional relationships with our senior author. Our goal was to highlight the environment of orthopedic trauma practices around the world in combatting COVID-19 in an efficient and expedient manner, which is why this method was chosen. Second is a lack of knowledge as to specifics of what type of COVID-19 testing participants were referring to as well as what specific types of PPE referenced by respondents. Lastly, there is subjectivity in relying on surgeon's knowledge for percentage of ICU patients occupied by COVID-19 (+) patients and COVID testing data. However, these numbers were validated with official sources whenever the data was available.

Conclusion {#Sec10}
==========

To our knowledge, this is the largest data set characterizing the different COVID-19 situations and responses of orthopedic trauma practices around the world. There is much to be learned from each of these participants' responses. Furthermore, the distribution and completion of this questionnaire highlight the power of worldwide communication and coordination. In a short period of time, 63 orthopaedic trauma surgeons from 28 different countries were able to describe their unique challenges as it relates to their orthopaedic practice and hospital combatting the COVID-19 pandemic. It is important that we recognize the power of global communication and coordinated responses, learning from each other's successes and failures alike, in order to prevent a global pandemic like we are living through now from occurring again in the future.
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